May 2026
📣 VC round data is live. Check it out!
Largest AgriTech Public Companies in Japan
Benchmark revenue and EBITDA valuation multiples for public comps like
NEXTAGE, Izumi Co, Takara Bio and Seiwa Holdings Co.
 | NEXTAGE Co Ltd is principally engaged in the dealing of used cars. It is primarily involved in operation, maintenance, insurance agency and automobile dealing of retails used domestic cars as well as sells imported cars and SUV/vans. In addition, the company operates an automobile maintenance business. | $23 | +123% | $2B | $2B | 0.6x | 14.1x | ||
| Izumi Co Ltd is engaged in operating shopping centres, general merchandising stores, clothing, household goods and food products. Most of the stores are located in Kyushu Region, Chugoku Region, and Shikoku Region in Japan. The company operates through segments including retail, retail-peripheral operations, and other. The retail segment is engaged in the retail business through shopping centres. The retail-peripheral operations segment consists of a credit and finance business, shop facility management, and restaurant operation, which deliver the vast majority of the business' income. The other segment includes wholesale and real estate operations. | $6 | -- | $1B | $2B | 0.6x | 7.0x | ||
| Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment. | $7 | +46% | $878M | $815M | 2.6x | 17.9x | ||
| Seiwa Holdings Co Ltd is focused on the promotion of business succession in the manufacturing sector, and Group management through platformization. | $14 | -- | $261M | $289M | 5.8x | 42.1x | ||
| Median | $11 | +85% | $1B | $1B | 1.6x | 16.0x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.